Healthcare provider profile · identity verified

Eamonn M Keane, MD

Family Practice · PERU, IN · NPI 1750558136

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	482	79
Amlodipine Besylate	Amlodipine Besylate	359	51
Levothyroxine Sodium	Levothyroxine Sodium	341	48
Donepezil Hcl	Donepezil Hcl	273	30
Eliquis	Apixaban	263	29
Furosemide	Furosemide	251	44
Metoprolol Tartrate	Metoprolol Tartrate	251	35
Omeprazole	Omeprazole	214	41
Pantoprazole Sodium	Pantoprazole Sodium	200	35
Gabapentin	Gabapentin	187	32
Famotidine	Famotidine	172	26
Sertraline Hcl	Sertraline Hcl	165	26
Lisinopril	Lisinopril	143	28
Duloxetine Hcl	Duloxetine Hcl	138	19
Metoprolol Succinate	Metoprolol Succinate	136	25
Potassium Chloride	Potassium Chloride	136	27
Memantine Hcl	Memantine Hcl	131	14
Escitalopram Oxalate	Escitalopram Oxalate	130	19
Buspirone Hcl	Buspirone Hcl	127	23
Tamsulosin Hcl	Tamsulosin Hcl	126	23
Trazodone Hcl	Trazodone Hcl	121	22
Losartan Potassium	Losartan Potassium	119	22
Alendronate Sodium	Alendronate Sodium	115	suppressed
Carvedilol	Carvedilol	104	14
Quetiapine Fumarate	Quetiapine Fumarate	99	20
Clopidogrel	Clopidogrel Bisulfate	88	13
Levetiracetam	Levetiracetam	85	15
Spironolactone	Spironolactone	84	suppressed
Metformin Hcl	Metformin Hcl	82	17
Allopurinol	Allopurinol	79	16
Pravastatin Sodium	Pravastatin Sodium	73	suppressed
Torsemide	Torsemide	70	13
Risperidone	Risperidone	60	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	20
Citalopram Hbr	Citalopram Hydrobromide	57	13
Mirtazapine	Mirtazapine	56	13
Trintellix	Vortioxetine Hydrobromide	56	suppressed
Hydralazine Hcl	Hydralazine Hcl	54	suppressed
Baclofen	Baclofen	53	11
Bupropion Hcl Sr	Bupropion Hcl	52	suppressed
Ezetimibe	Ezetimibe	52	suppressed
Ropinirole Hcl	Ropinirole Hcl	52	suppressed
Warfarin Sodium	Warfarin Sodium	50	suppressed
Cephalexin	Cephalexin	48	37
Nifedipine Er	Nifedipine	47	suppressed
Paroxetine Hcl	Paroxetine Hcl	46	suppressed
Breo Ellipta	Fluticasone/Vilanterol	45	suppressed
Divalproex Sodium	Divalproex Sodium	45	suppressed
Prednisone	Prednisone	42	16
Hydrochlorothiazide	Hydrochlorothiazide	40	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	40	suppressed
Ondansetron Odt	Ondansetron	37	24
Xarelto	Rivaroxaban	37	suppressed
Jardiance	Empagliflozin	36	suppressed
Finasteride	Finasteride	35	suppressed
Oxcarbazepine	Oxcarbazepine	35	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	35	suppressed
Myrbetriq	Mirabegron	34	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	33	suppressed
Midodrine Hcl	Midodrine Hcl	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	26
Sotalol	Sotalol Hcl	31	suppressed
Creon	Lipase/Protease/Amylase	30	suppressed
Entresto	Sacubitril/Valsartan	30	suppressed
Lamotrigine	Lamotrigine	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	29
Lovastatin	Lovastatin	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	23
Humalog Kwikpen U-100	Insulin Lispro	28	suppressed
Klor-Con M20	Potassium Chloride	28	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Celecoxib	Celecoxib	27	suppressed
Aptiom	Eslicarbazepine Acetate	26	suppressed
Brilinta	Ticagrelor	26	suppressed
Bumetanide	Bumetanide	26	suppressed
Clozapine	Clozapine	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Renvela	Sevelamer Carbonate	26	suppressed
Olanzapine	Olanzapine	25	suppressed
Benztropine Mesylate	Benztropine Mesylate	24	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Memantine Hcl Er	Memantine Hcl	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	suppressed
Levofloxacin	Levofloxacin	23	14
Metformin Hcl Er	Metformin Hcl	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Simvastatin	Simvastatin	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	22	11
Methimazole	Methimazole	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Amantadine	Amantadine Hcl	20	suppressed
Naproxen	Naproxen	20	19
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	14
Albuterol Sulfate Hfa	Albuterol Sulfate	19	14
Benazepril Hcl	Benazepril Hcl	19	suppressed
Bethanechol Chloride	Bethanechol Chloride	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Methylprednisolone	Methylprednisolone	19	19
Primidone	Primidone	19	suppressed
Folic Acid	Folic Acid	18	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Scopolamine	Scopolamine	18	suppressed
Topiramate	Topiramate	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Calcitriol	Calcitriol	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	11
Digoxin	Digoxin	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	suppressed
Dutasteride	Dutasteride	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	12
Rivastigmine	Rivastigmine Tartrate	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Xifaxan	Rifaximin	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Mesalamine Er	Mesalamine	14	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	14	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	13	12
Clonidine Hcl	Clonidine Hcl	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Nateglinide	Nateglinide	13	suppressed
Nystatin	Nystatin	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Ursodiol	Ursodiol	13	suppressed
Acetazolamide	Acetazolamide	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Minoxidil	Minoxidil	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Ceftriaxone	Ceftriaxone Sodium	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Dorzolamide-Timolol	Dorzolamide/Timolol/Pf	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	11
Loperamide	Loperamide Hcl	11	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Roflumilast	Roflumilast	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error